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Sin Nombre virus (SNV) was isolated and
characterized as the cause of the 1993 cluster of
17 cases of hantavirus pulmonary syndrome
(HPS) in the southwestern United States (1,2).
HPS cases in other states were predicted because
of the widespread distribution of the rodent hosts
of hantavirus (2). Subsequent reports described
human infection with and rodent carriage of
novel genomic variants of hantavirus in New
York (3), Florida (4), and Louisiana (5). Each of
the four initially characterized strains of
hantavirus causing HPS in North America is
carried by a primary rodent host species,
although spillover to other rodents in the area
can occur (6-9).
We describe the first two recognized cases of
HPS acquired in Pennsylvania; both were fatal
and at least one was caused by infection with the
newly characterized Monongahela variant of
hantavirus (10). This variant can be present in
Peromyscus leucopus mice, in addition to
P. maniculatus nubiterrae with which they often
share microhabitat.
Case Reports
Case 1. A 40-year-old, previously healthy
crossbow hunter was taken by ambulance to a
Lehigh County, Pennsylvania, hospital in
November 1997, with complaints of back muscle
pain, dizziness, diarrhea, fever, and abdominal
pain of 3 days’ duration. He had been taking oral
penicillin and ibuprofen for several weeks for a
chronically infected tooth, and initially his
symptoms were attributed to severe dental
infection or antibiotic-associated diarrhea. A
chest X-ray at the time of the first emergency
room visit was normal. The patient was given
intravenous fluids and was referred for dental
extraction, but he was hospitalized the next day
for progressively severe respiratory and general-
ized systemic distress. He was transferred to the
intensive care unit, where he was placed on
mechanical ventilation 11 hours after hospital
admission because of increasing respiratory
failure. Sputum, blood, and urine cultures and
Gram stains were negative or nondiagnostic;
these tests included respiratory viral cultures for
respiratory syncytial virus; adenovirus; parain-
fluenza virus types 1, 2, 3; and influenza virus
types A and B (Table 1). Chest X-rays over a 3-day
period showed pleural effusions and progressive,
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refractory bilateral pulmonary infiltrates, ini-
tially interstitial then alveolar. Intravenous
therapies included fluids, vasopressors, and
inotropic agents, including dobutamine, dopam-
ine, and norepinephrine. Antimicrobial drugs
administered during the hospital stay included
azithromycin, ceftriaxone, doxycycline,
clindamycin, levofloxacin, and trimethoprim/
sulfamethoxazole. The patient’s fever persisted
throughout the 3-day hospital stay, his pulmo-
nary and cardiac status deteriorated, and he died
5 days after onset of illness, despite intensive
critical care support.
Hantavirus infection was confirmed by both
immunohistochemical study of lung and kidney
tissue, using a cross-reactive monoclonal anti-
body (GB04-BF07) as described (11). Enzyme-
linked immunosorbent assay for serum anti-
bodies showed an immunoglobulin (Ig) G titer of
1:400 and an IgM titer of 1:1600 for Sin Nombre
antibody.
Patient 1 lived in a rural area in Upper
Macungie Township near Allentown, Pennsylva-
nia (Figure 1).  In the 8 weeks before his death, he
hunted deer almost every day and was
potentially exposed to mouse habitats in four
Pennsylvania counties. The longest exposure
was a 3-day, 2-night stay in a small cabin near
Germania in Potter County, Pennsylvania
(Figure 1), 3 weeks before onset of illness. The
patient slept on a mattress in a loft. During an
investigation of the cabin in December 1997,
rodent droppings were found on the loft floor
around the mattress. A dead Peromyscus
leucopus  (white-footed mouse) was found in a
trap on the cabin floor. When unoccupied, the
cabin was closed and the downstairs windows
were boarded shut. On January 6, 1998, 70 live
traps were set in and around the cabin. Eleven
small mammals were captured: seven P. leucopus,
two P. maniculatus (deer mouse), one Clethrion-
omys gapperi (red-backed vole), and one Blarina
brevicauda (short-tailed shrew). The animals
were anesthetized and bled through a capillary
tube from the periorbital sinus. Blood was placed
on Nobuto blood collection strips, air-dried, and
analyzed for hantavirus antibodies. Lungs were
collected from the mammals, placed on ice, and
kept frozen at -70°C until virus isolation.
Patient 1 had also cleaned a small trailer
near Zion Grove in Schuylkill County, Pennsyl-
vania, approximately 6 weeks before onset of
illness, and had noted mouse droppings there. He
hunted avidly with a crossbow, often from shelter
blinds on Doe Mountain in Berks County,
Pennsylvania, in the 8 weeks before his illness.
Case 2. A 39-year-old machine shop worker
and mother of two children visited a Monroe
County, Pennsylvania, hospital emergency de-
partment in March 1997. She had fever,
myalgias, profound weakness, cough, and
shortness of breath, and had not urinated for 3
days. She received intravenous fluids, and
Table 1. Laboratory data
   Hantavirus pulmonary syndrome           Hantavirus pulmonary syndrome
Complete blood count Patient 1 Patient 2
Date  3/10/97 3/12/97 3/13/97 11/13/97 11/14/97 11/15/97 11/16/97
Time    2057   1443   0700  1100    1356    1856    0450    0400  0925
White blood cells   4,300  4,800 12,100 10,900   4,400    5,100   8,000  11,100 15,700
Polymorpho nuclear     58    60     45    53      67      62      81      58    73
  cells (percent)
Bands (percent)      3    23     34    27       0       9     N/D      11    N/D
Immunoblasts      4     1      3     5       2    N/D     N/D     N/D    N/D
Platelets 100,000 27,000 13,000  2,000 128,000  74,000   59,000
Hematocrit    45.9   47.0   55.5   44.0    47.4    46.4    48.2
Creatinine (mg/dL)      0.8     0.8     1.9      1.2      1.1      1.0
Figure 1. Pennsylvania county map highlighting the
four counties involved (Potter, Schuylkill, Lehigh, and
Berks) in the environmental investigations of Patient
1, and the single county of residence (Monroe) and
rodent exposure of Patient 2.618
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laboratory testing was performed (Table 1).
Because of acteriuria, an initial diagnosis of
urinary tract infection was made. Treatment
with clarithromycin and cefuroxime oral antimi-
crobial drugs was initiated, and the patient was
discharged; 48 hours later, she returned to the
hospital, complaining of severe backache,
dizziness, abdominal pain, and shortness of
breath. She was admitted to the hospital and 12
hours later was placed on mechanical ventilation
because of respiratory distress. She rapidly
became progressively hypotensive despite fluid
and inotropic therapy, and she died on hospital
day 2, day 5 after onset of illness. Antimicrobial
drugs administered included erythromycin,
ceftazidime, and cefotaxime. Blood cultures
remained sterile, and sputum cultures grew oral
flora. A urine culture taken at admission yielded
>100,000 Escherichia coli/mL. A year after the
patient’s death, immunohistochemical testing of
archival tissue from an initially nondiagnostic
autopsy confirmed the diagnosis of HPS. No
serum was available for testing.
Patient 2 lived in a mobile home in a rural,
wooded area near Cresco, Barrett Township,
Monroe County, Pennsylvania (Figure 1). The
machine shop where she worked was also in an
isolated area. Family members stated that she
had not left the area for several months before
her death. During the environmental studies
begun 14 months after the patient’s death, rodent
droppings were found under the kitchen sink of
her home. That evening, 70 rodent live traps were
placed in and around the mobile home, and six
P. leucopus mice were captured. The rodents
were bled, and lung tissue was collected. On June
2, 1998, the machine shop was examined, but no
evidence of rodent activity was noted. Seventy
traps were set in and around the shop. Six
P. leucopus, one Tamias striatus (eastern
chipmunk), and one B. brevicauda were captured
in the surrounding wooded area; no rodents were
captured inside the building.
Materials and Methods
RNA Extraction, Reverse
Transcription-Polymerase Chain
Reaction (RT-PCR), and
Genetic Analysis
RNA was extracted from Patient 1’s lung
tissue, and RT-PCR and nucleotide sequence
analysis were carried out as described (12). RNA
was also extracted from six seropositive rodents,
and RT-PCR and nucleotide sequence analysis
were performed (13).
Results
Genetic Analysis of Virus from Lung Tissue
The nucleotide sequences of the fragments S,
M-G1, and M-G2 were compared with the
equivalent regions of other previously character-
ized  Peromyscus-associated hantavirus. The
hantavirus in Patient 1’s lung was clearly
identified as Monongahela virus, which was first
detected in P. maniculatus nubiterrae (Cloudland
deer mice) captured in West Virginia in 1985 (10).
Virus S segment fragment showed 95.7%
nucleotide identity and 100% deduced amino acid
compared with the Monongahela-1 virus strain.
A shorter, overlapping fragment (246 nucleotide)
was available to compare with the Monongahela-
3 virus strain. Again, a 96.7% nucleotide identity
and 100% amino acid identity were found. Other
Peromyscus-borne hantaviruses were more dis-
tantly related. Comparison of this patient’s
hantavirus sequence with those of New York
virus (strains NY-1 and RI-1) and SNV (strains
NMH10, CC74 and CC107) identified a nucle-
otide difference of 14.8% to 19.6% and an amino
acid difference of 2.3% to 3.1% (14-16).
Results were similar, with 95.1% nucleotide
and 100% amino acid identity, when the virus M-
G2 fragment sequence from Patient 1 was
compared with the Monongahela-2 virus strain.
Nucleotide and amino acid differences of 15.6% to
21.5% and 1.5% to 7.4%, respectively, were seen
when this fragment was compared with the more
distantly related Peromyscus-borne hantaviruses,
including Blue River virus (strains Indiana and
Oklahoma), New York virus (strains RI-1, NY-1,
and NY-2), and SNV (strains NM H10, CC74, and
CC107) (15-19). No comparable piece of
Monongahela virus sequence was available to
align with the virus M-G1 fragment from this
patient. However, sequence identity differences
of 15.1% to 18.1% and 3.5% to 7.0% were seen at
the nucleotide and amino acid levels, respec-
tively, when the patient M-G1 sequence was
compared with those of the other Peromyscus-
associated hantaviruses.
Analysis of Rodent Samples
Three of seven P. leucopus mice (PA1, PA,
and PA9) trapped at the suspected exposure site619
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for Patient 1 in Potter County and three of six
P. leucopus mice (MC-3, MC-4, and MC-6)
trapped at the Monroe County location (sus-
pected exposure site for Patient 2) contained
hantavirus-specific antibodies. With the excep-
tion of MC-3, Monongahela virus-specific RNA
was detected in each of the seropositive rodents
by RT-PCR. P. leucopus MC-3 was a juvenile
mouse, suggesting that maternal antibody may
have been detected. The virus nucleotide
sequences obtained from the Potter County mice
closely matched those obtained in Case 1, with
the M-G1 PCR fragment sequences being
identical. The virus nucleotide sequence frag-
ments obtained from the Monroe County mice
differed from those from Patient 1 and the Potter
County rodent samples by approximately 10%.
A detailed phylogenetic analysis of the M-G2
fragment sequences of these and other published
hantavirus sequences was carried out. A 50%
majority rule consensus tree was generated by
bootstrap analysis with 1,000 replications
(Figure 2). Hantaan and Seoul hantavirus
sequences were used as an outgroup. This
analysis showed that the viruses detected in
Patient 1 (human 584) and rodents (PA1, Potter
County; and MC-4, Monroe County) were
clustered in the Monongahela virus lineage.
Pathology
Examination of lung tissue from Patient 1 by
microscopy showed a mild to moderate intersti-
tial pneumonitis, with mononuclear infiltration
and congestion, and edema typical of HPS.
Typical immunoblasts were seen within the red
pulp in periarteriolar sheaths of the spleen.
Immunohistochemical examination showed wide-
spread staining of hantavirus antigens within
Figure 2. Phylogram of the 139-bp
fragments of the G2 coding region.1
The number above the branch is the
bootstrap probability (shown as
percentages). HTN Apag - Hantaan
virus strain 76-118, Apodemus
agrarius; SEO Rn sr11 - Seoul virus
strain SR-11, Rattus norvegicus;
BAY - Bayou virus; BCC Shisp -
Black creek canal virus, Sigmodon
hispidus; Pm - Peromyscus manicu-
latus; NM - New Mexico; Pl -
Peromyscus leucopus; PH Mpenn -
Prospect Hill, Microtus pennsylvan-
icus; TULA Mross - Tula, Microtus
rossiaemeridionalis; ELMC Rm 97 -
El Moro Canyon virus, Reithrodon-
tomys megalotis; PUU Cg - Puuma-
la virus, Clethrionomys glareolus.
1Three fragments of the virus genome
were amplified by nested polymerase
chain reaction to allow generation of
nucleotide (nt) sequences 393 nt in
length for an S segment region encoding
the N protein, 259 nt in length for an M
segment region (M-G1) encoding the G1
protein, and 205 nt in length for an M
segment region (M-G2) encoding the G2
protein (12). Sequence data were
analyzed by using the Wisconsin GCG
Package (version 9.1) software. Initial
multiple sequence alignment was done
with the GCG Pileup program, and
phylogenetic analysis was performed by
using the Phylogenetic Analysis Using
Parsimony (*and other methods) pro-
gram (version 4.0) (20).620
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endothelial and follicular dendritic cells, similar
to the pattern seen in previous cases of HPS.
However, instead of the typical granular
staining, the lung immunostaining was more
linear and curvilinear, similar to staining seen in
infections with Hantaan virus. The immun-
ostaining in the kidney was also more abundant
than with typical HPS cases.
Conclusions
We describe two Pennsylvania cases that add
incrementally to knowledge about North Ameri-
can hantavirus. Rodent hosts carrying hantavirus
in an asymptomatic but communicable form are
found in most areas of North America (21).
Clinicians should be vigilant for possible cases of
HPS, even in areas where no cases have been
previously recognized.
These Pennsylvania cases share with earlier
(2) and more recently described cases (22) the
clinical picture of a nonspecific and often
nonpulmonary flulike prodromal phase. The
surprising rapidity with which noncardiogenic
pulmonary edema affects often previously
healthy victims separates HPS from many other
common febrile diseases seen in North America.
Some reports have suggested that patients be
transferred to facilities with extracorporeal
membrane oxygenation capability for patients
who do not respond to respiratory and inotropic
support (23). However, data may be insufficient
to establish the precise role of extracorporeal
membrane oxygenation support in the manage-
ment of these patients (24).
These Pennsylvania cases also reflect the
first report of human infection with the
Monongahela variant of hantavirus. The initial
description of this strain was from archival tissue
of  P. maniculatus nubiterrae captured in the
Monongahela National Forest in West Virginia.
Retrospective serologic diagnoses of HPS have
been made in nonfatal human cases from
Virginia and West Virginia, but none of these
cases, to our knowledge, have had  RT-PCR
confirmation of the Monongahela variant. Recent
analysis of hantavirus RNA and rodent mito-
chondrial DNA has shown genetically distinct
clades of virus and rodents useful in understand-
ing suspected cospeciation of virus types within
host rodent subspecies (25-27). Monongahela
hantavirus appears to be closer in evolutionary
distance to the New York/Rhode Island strains
than to SNV strains found in the midwestern and
southwestern United States (16). Finding
Monongahela variant of hantavirus in both
P. leucopus and P. maniculatus can be explained
by spillover between the two mouse species,
given their frequent sympatric and synchronistic
existence (16). Allopatric migrations and other
biogeographic influences may explain the
existence of hantavirus variants in more than one
species or subspecies of host rodent (16).
Given the complexity of the genetic relation-
ships between the Peromycine-borne
hantaviruses, it is unclear whether the
Monongahela virus lineage will be considered a
distinct hantavirus species or a subspecies of
SNV (18). However, the pathologic findings in
Monongahela-associated HPS, together with its
primary association with a distinct P. maniculatus
subspecies, suggest biologic differences between
Monongahela virus and classic SNV lineages.
Clinical differences have been noted for HPS
cases due to different hantavirus types in North
and South America. Renal disease and myositis
are more evident in patients infected with
hantavirus carried by Sigmodon sp. and
Oryzomys sp. than by Peromyscus sp.(4). The
unusual linear immunohistochemical immun-
ostaining and heavy renal staining seen in
autopsy material from the two Pennsylvania
HPS cases may also have clinical importance.
The ultimate goals of effective treatment and
prevention of HPS will require continued close
cooperation between clinicians, laboratorians,
virologists, mammalogists, and epidemiologists.
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